Open Your FREE Demat Account Now!

Nath Bio-Genes (India) Ltd. Share Price

NSE
BSE

NSE : NATHBIOGEN

BSE : 537291

Sector : Agri

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹138.70

High

₹145.00

Price Summary

Previous Close ₹141.72
Day's Range ₹138.70 - ₹145.00
Open ₹141.00
52 Week Range ₹126.15 - ₹204.00
Volume 11,143
Market Cap ₹0.00
Previous Close ₹142.45
Day's Range ₹138.10 - ₹150.00
Open ₹141.50
52 Week Range ₹126.75 - ₹207.00
Volume 3,881
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 15.79
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 1.43
Price/Earning (TTM) 7.28
TTM EPS (₹) 19.26
P/E Ratio 5.83
Book Value(₹) 0.37
PAT Margin (%) 9.35
Face Value (₹) 10.00
ROCE(%) 7.88
Trade Value ( ₹ in Lacs) 5.53
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 1.43
Price/Earning (TTM) 7.28
TTM EPS (₹) 19.26
P/E Ratio 5.83
Book Value(₹) 0.37
PAT Margin (%) 9.35
Face Value (₹) 10.00
ROCE(%) 7.88

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 2801.72 3623.08
Expenses N/A N/A
PBT 298.65 441.25
Operating profit 0.0 0.0
Net profit 292.06 421.4

Shareholding Pattern

Promoters (% Holding)

45.60%

Mutual funds (% Holding)

0.01%

Non-Institution (% Holding)

54.21%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.18%

About Nath Bio-Genes (India) Ltd.

Founded 2000
Managing Director Satish Kagliwal
NSE Symbol NATHBIOGEN

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Tata Consumer Products Ltd. 1,07,382.30 1,079.00 916.00 - 916.00
Balrampur Chini Mills Ltd. 13,694.28 657.80 393.55 - 393.55
CCL Products (India) Ltd. 13,203.91 977.50 885.70 - 885.70
E.I.D. - Parry (India) Ltd. 11,918.58 655.10 594.35 - 594.35
Gujarat Ambuja Exports Ltd. 6,818.14 146.75 102.05 - 102.05
Triveni Engineering & Industries Ltd. 5,469.41 252.60 220.05 - 220.05
Bajaj Hindusthan Sugar Ltd. 4,360.57 18.36 14.85 - 14.85
Shree Renuka Sugars Ltd. 3,956.86 18.50 17.14 - 17.14
Bannari Amman Sugars Ltd. 3,953.58 3,116.00 3,061.30 - 3,061.30
Dalmia Bharat Sugar And Industries Ltd. 3,905.32 491.75 261.40 - 261.40
no-content No Records Found

Latest News

Nov
13
2026
EQUITY Posted on Nov 13th 2026

Yashhtej Industries (India) informs about outcome of board meeting

Pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Yashhtej Industries (India) has informed that the Board of Directors of the Company in their meeting held on Friday, November 13, 2026, at the Registered Office of the Company situated at Plot No. D-73/1, Additional MIDC, Latur-413512, Maharashtra, India, has transacted the following main business: 1) Considered and approved the Unaudited Standalone Financial Results for the Half Year ended September 30, 2026, along with the Statement of Assets and Liabilities and Cash Flow Statement for the Half Year ended September 30, 2026; A copy of the Financial Results along with the Auditor’s Limited Review Report is enclosed as Annexure-A. 2). Approved the appointment of Krupa Mayankkumar Gandhi (Membership No. A82371) as the Company Secretary and Compliance Officer of the Company with effect from November 13, 2026. The details as required under Regulation 30 read with SEBI Master Circular HO/49/14/14(7)2025-CFDPOD2/1/3762/2026 dated January 30, 2026 is enclosed as Annexure-B. The Board Meeting commenced at 12:15 PM and concluded at 3:00 PM. 

The above information is a part of company’s filings submitted to BSE.

Read More
Nov
13
2026
EQUITY Posted on Nov 13th 2026

Zuari Industries informs about newspaper publications

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Zuari Industries informed that it enclosed copies of the newspaper publications, as published today, 13th November 2026 in Business Standard (All India editions, English except Ahmedabad, where the publication is scheduled for 14th November 2026 and Lokmat (Regional newspaper), for the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September 2026.

The above information is a part of company’s filings submitted to BSE.

Read More
Nov
13
2026
EQUITY Posted on Nov 13th 2026

Eastern Treads informs about press release

Eastern Treads has informed that it enclosed the copy of Newspaper publication of the extract of unaudited financial results for the quarter ended September 30, 2026 in Financial Express (English) and Deepika (Regional Language) on today, November 13, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
13
2026
EQUITY Posted on Nov 13th 2026

Davangere Sugar Company informs about outcome of the board meeting

Pursuant to Regulations 30 and 33 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Davangere Sugar Company has informed that the Board of Directors of the Company, at its meeting held on Thursday, November 12, 2026, has, considered and approved the Unaudited Financial Results of the Company (Standalone and Consolidated) for the quarter and half year ended September 30, 2026. In this regard, it has enclosed the following: 1. Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026, along with the Statement of Assets and Liabilities and the Cash Flow Statement; and 2. Limited Review Reports of the Statutory Auditors on the Unaudited Financial Results (Standalone and Consolidated) for the said period. The meeting of Board of Directors commenced at 07:30 PM (IST) and concluded at 08:30 PM (IST). The above information is also being made available on the Company’s website at https://davangeresugar.com/. 

The above information is a part of company’s filings submitted to BSE.

Read More
Nov
13
2026
COMPANY Posted on Nov 13th 2026

Eastern Treads - Quaterly Results

The quarter ended September 2026 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 164.59 millions.The Net Loss for the quarter ended September 2026 is Rs. -10.44 millions as compared to Net Loss of Rs. -5.35 millions of corresponding quarter ended September 2025Operating profit Margin for the quarter ended September 2026 slipped to -0.56% as compared to 3.16% of corresponding quarter ended September 2025
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 164.59 161.32 2.03 305.14 327.81 -6.92 624.11 602.33 3.62
Other Income 0.52 0.86 -39.53 1.58 2.14 -26.17 3.48 3.93 -11.45
PBIDT -0.56 3.16 -117.72 7.78 9.57 -18.70 11.34 -4.84 -334.30
Interest 8.22 6.67 23.24 16.41 12.57 30.55 23.82 24.60 -3.17
PBDT -8.78 -3.51 150.14 -8.63 -3.00 187.67 8.02 -29.44 -127.24
Depreciation 1.66 1.84 -9.78 3.46 3.76 -7.98 7.43 8.39 -11.44
PBT -10.44 -5.35 95.14 -12.09 -6.76 78.85 0.59 -37.83 -101.56
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -0.27 -7.53 -96.41
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.27 -7.53 -96.41
PAT -10.44 -5.35 95.14 -12.09 -6.76 78.85 0.86 -30.30 -102.84
Equity 52.33 52.32 0.02 52.33 52.32 0.02 52.33 52.32 0.02
PBIDTM(%) -0.34 1.96 -117.37 2.55 2.92 -12.67 1.82 -0.80 -326.11
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Nath Bio-Genes (India) Ltd. ?

The current share price of Nath Bio-Genes (India) Ltd. is ₹141.72 as of 2026-11-13.

The market capitalisation of Nath Bio-Genes (India) Ltd. is ₹266.63 as of 2026-11-12.

The 1-year return of Nath Bio-Genes (India) Ltd. is -24.63% as of 2026-11-13.

The P/E ratio of Nath Bio-Genes (India) Ltd. is 5.83 as of 2026-11-13.

The 52-week high and low of Nath Bio-Genes (India) Ltd. are ₹204.00 and ₹126.15, respectively, as of 2026-11-13.

The dividend yield of Nath Bio-Genes (India) Ltd. is 1.4255% as of2026-11-12.

You can buy Nath Bio-Genes (India) Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Nath Bio-Genes (India) Ltd. is Satish Kagliwal.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore